Showing results (11-20 of 2,104) with videos related to
Sort By:
Pageof 211
CNS Drugs|November 8, 2002
Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosisDene Simpson, Stuart Noble, Caroline PerryCNS Drugs|October 18, 2002
Antipsychotic-induced venous thromboembolism: a review of the evidenceStaffan Hägg, Olav SpigsetCNS Drugs|October 17, 2001
Calcitonin gene-related peptide (CGRP) and the pathophysiology of headache: therapeutic implicationsL EdvinssonCNS Drugs|October 17, 2001
Design of clinical trials of antidepressants: should a placebo control arm be included?J Fritze, H J MöllerCNS Drugs|May 8, 2002
CNS manifestations of cytomegalovirus infections: diagnosis and treatmentMatthias Maschke, Oliver Kastrup, Hans-Christoph DienerCNS Drugs|May 8, 2002
Genetic predictors of therapeutic response to clozapine: current status of researchDalu Mancama, Maria J Arranz, Robert W KerwinCNS Drugs|July 5, 2002
Newer antiepileptic drugs in bipolar disorder: rationale for use and role in therapyKathryn J Macdonald, L Trevor YoungCNS Drugs|July 5, 2002
Comparative assessment of immunomodulating therapies for relapsing-remitting multiple sclerosisOmar Khan, Rana Zabad, Christina Caon, et al.CNS Drugs|May 25, 2002
Morphological brain changes in depression: can antidepressants reverse them?José Javier Miguel-Hidalgo, Grazyna RajkowskaCNS Drugs|May 25, 2002
Differentiation of multiple sclerosis subtypes: implications for treatmentAndreas Bitsch, Wolfgang BrückPageof 211